Posts Tagged needlestick statistics

Analysis of safety syringe market

Wednesday, January 4th, 2012 | Permalink

One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.

Till date, none of the European countries has introduced clear rules governing the usage of safety devices or making their use mandatory. Some countries such as Germany have issued broad directives but these are meant to be guidelines and leave the final decision to the discretion of the purchasing agency.

New analysis from Frost & Sullivan reveals that the European safety syringes market generated a market revenue of USD 13 million in 2003 and is projected to double by 2010.

Given that needlestick injuries amount to a staggering one million in Europe every year, and that 16 to 25 per cent of these are linked to the usage of single-use syringes, the market for safety syringes – which prevent needlestick injuries as well as discourage reuse – looks extremely promising.

“A legislation that is sympathetic to the problems faced by the number of needlestick injuries occurring in Europe and the hazards of infection by over 20 pathogens that health workers face is needed,” comments Frost & Sullivan Research Analyst Kavitha Ravikumar. “This will not only be socially lauded but also act as an effective driver to the safety syringes market.”

The Needlestick Prevention Act introduced in the United States represents the first true legislation towards mandating the use of safety engineered products in health care settings. This landmark legislation was introduced to address the growing concern of the health care industry for the safety of its employees. With the spread of blood-borne diseases such as AIDS and hepatitis, there is now, more than ever, an urgent need for safer devices that eliminate needlestick injuries.

Huge health care expenditure on drug-related infections – over USD 900 million in the case of Spain and about USD 700 million in the case of Italy – can also be potentially controlled if syringe reuse and needle sharing become difficult due to distribution of safety syringes in place of the ordinary ones.

The Needlestick Prevention Act has been instrumental in opening up a new market with considerable potential – the European market. While this market is still relatively very small, the increasing awareness of safety issues and the demands of health care workers for safer work environments are expected to help it grow significantly in the future.

Meanwhile, in the absence of specific government legislation, safety syringe manufacturers must consider supporting movements lobbying for such laws and simultaneously work at raising awareness of safety issues and the drawbacks of not using safety devices.

Currently, it is estimated that over 50 per cent of ordinary syringes have the potential to be replaced by safety products. This number is expected to rise to considerably in 2010 due to technological advances. Market penetration is also set to show substantial long-term increases from the presently low levels of 2.5 per cent.

However, the high prices of safety syringes are likely to be a major constraint to market growth. These devices are perceived to be far too expensive at a time when almost all end-user markets are focused on cost-cutting.

In spite of their proven advantages over ordinary syringes, adoption by healthcare agencies has not been very significant. Cost of new technology in a growing market combined with small-sized end-user markets is likely to continue to keep prices high.

“Participants can consider applying for subsidies and exemptions on the welfare and citizen protection platform to bring down manufacturing costs, and consequently product prices,” says Ms. Ravikumar. “Passing on the benefits of economies of scale can also help lower prices and drive demand for safety syringes.”

With syringes being a commodity market, there is a strong need to play up the innovation and technology benefits of these products. Companies must concentrate on the prestige and reputation associated with having safety products in their portfolios, particularly in premium and specialty health care areas.

Potentially dangerous needlestick injuries often go unreported « QD …

Wednesday, January 4th, 2012 | Permalink

Search: QD Syringe Systems ™ · About. Potentially dangerous …. About. QD Syringe Systems ™. RSS . RSS Feed for QD Syringe Systems ™ Complete Feed; RSS Feed for QD Syringe Systems ™ comments Comments …

Potentially dangerous needlestick injuries often go unreported « QD …

Most healthcare workers do not believe that syringe needlestick injuries have been eliminated

Wednesday, January 4th, 2012 | Permalink

MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, surveyed 262 healthcare professionals at the APIC 2011 Annual Educational Conference held in June 2011. The survey’s key findings include:

“We gathered helpful insights from the survey of healthcare professionals at APIC”

  • 68% of healthcare workers do not believe that syringe needlestick injuries have been eliminated at their institutions, despite FDA, CDC, and OSHA requirements in place for more than a decade.
  • 43% do not believe the safety features that prevent needlestick injury are always activated after use and prior to disposal at their institutions, and less than 40% check for activation.
  • 43% are not happy or ambivalent with the current syringes used at their institutions.

These findings indicate a high degree of concern among healthcare professionals about the risk of needlestick injuries from the syringes currently used by their institutions. Survey questions also focused on brands, pricing and other features, including ease of use. MedPro’s blood collection product line offers a passive safety mechanism that is automatically activated, allowing clinicians to deploy it safely without adding steps to the procedure.

MedPro develops safer medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) systems. Unlike competitive safety needle products currently on the market, MedPro’s safety features operate without user activation, and therefore require little or no clinician training to use.

“We gathered helpful insights from the survey of healthcare professionals at APIC,” said Bethany Denning, Director of Corporate Relations for MedPro Safety Products. “Our survey at ASHP will help us learn more from pharmacists and has been structured to provide additional information on issues of specific concern to these important professionals, including the benefits of prefilled drug delivery systems. We look forward to reviewing and being guided by the results.”

ASHP Conference

The Company will conduct a second survey at its Booth #1924 at the American Society of Health-System Pharmacists (ASHP) Midyear 2011 Clinical Meeting and Exhibition, December 4 through 8 in New Orleans, Louisiana. The survey will solicit pharmacists’ views of drug development and delivery, and how packaging issues impact workflow and patient safety. The survey will also focus on potential improvements to existing prefilled syringes and needlestick prevention technology.

Source MedPro Safety Products, Inc.





Contact Us

Click or drag a file to this area to upload.